improving the frontline treatment of dlbcl
Published 5 years ago • 73 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
2:18
the need for more effective, less toxic therapies in frontline dlbcl treatment
-
2:44
polarix study: frontline therapy in dlbcl
-
1:56
the need for new treatment strategies for patients with dlbcl
-
2:32
improving the treatment landscape for dlbcl patients
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
12:05
how to clean/change biobase hematology valves
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
29:38
dlbcl treatment approaches: what you need to know
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
1:52
an insight into the optimal management of patients with dlbcl
-
1:02
the changing standard of care in dlbcl
-
0:58
improving second-line treatments in dlbcl
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
1:25
can a avd replace pet-directed strategies for the frontline treatment of hodgkin lymphoma?
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
2:03
the next generation of novel agents in development for aggressive b-cell lymphoma
-
1:33
addressing the potential role of immunotherapy in the frontline treatment of all
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
4:01
first- and second-line treatment in dlbcl
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os